Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: University College London,
Woman and Man Max 99 years
University College London,
Update Il y a 4 ans
Phase II Study of Reduced Intensity Sibling Allogeneic Transplantation for Relapsed, Chemosensitive, PET Positive Hodgkin Lymphoma. Key words: Reduced intensity conditioning, Transplantation, Hodgkin lymphoma
To assess progression free survival following reduced intensity allogeneic transplantation in a relatively poor prognostic group of Hodgkin lymphoma patients, and allow comparison with historically ex...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
University College London,
Update Il y a 4 ans
A phase II multicentre trial of CVP, rituximab and gemcitabine for the treatment of patients with newly diagnosed diffuse large b-cell lymphoma considered unsuitable for r-chop chemotherapy
The aim of the trial is evaluate the objective overall response rate of R-GCVP in patients with diffuse large B-cell non-Hodgkin’s lymphoma who cannot receive R-CHOP chemotherapy due to poor cardiac...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
University College London,
Update Il y a 4 ans
Phase III, multicentre, randomised study of fludarabine/cyclophosphamide combination with or without Rituximab in patients with untreated mantle cell lymphoma
To evaluate the overall survival of patients treated with cyclophoshamide and fludarabine in comparison to rituximab, cyclophosphamide and fludarabine.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
University College London,
Update Il y a 4 ans
Improving the needs of people with dementia in care homes
Background and study aims Dementia is a term given to a group of conditions that involve the gradual decline of a person’s mental faculties. People with dementia have difficulties with mental processe...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
University College London, Joint Research Office
Update Il y a 4 ans
MULTI CENTRE CONTROLLED STUDY ON THE IMPACT OF STEM CELL DONATION EITHER AFTER MOBILISATION WITH GRANULOCYTE COLONY STIMULATING FACTOR OR BONE MARROW HARVEST ON UNRELATED BONE MARROW DONORS
The aim of this study is two fold a) Detection of any genetic differences between bone marrow and PBSC unrelated donors, 3-5 years post donation and confirm or refute the observations of “long-term g...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
University College London,
Update Il y a 4 ans
Transplantation of umbilical cord blood from unrelated donors in patients with haematological diseases using a myeloablative conditioning regimen
To assess the safety and efficacy of unrelated donor umbilical cord blood transplantation (UCBT) in a multi-institution UK setting where the use a myeloablative preparative regimen is indicated. The a...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
University College London,
Update Il y a 4 ans
PiPS2: A study investigating predictions about how long patients with advanced cancer have left to live
Lay summary under review by external organisation
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
University College London,
Update Il y a 4 ans
XERXES: Examining the role of early neoadjuvant and synchronous Erbitux in pre-operative chemo-radiotherapy using Xeloda followed by excisional surgery. A phase I/II dose escalation study of intravenous erbitux (cetuximab) in combination with 5 day weekly oral Xeloda (capecitabine) and preoperative radiotherapy in rectal cancer
To evaluate the safety and toxicity of the combination of erbitux, capecitabine and radiotherapy. This will be determined through an assessment of the patient’s toxicity
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
University College London,
Update Il y a 4 ans
Cardamon: a trial of carfilzomib, cyclophosmamide & dexamethasone with maintenance carfilzomib in patients with symptomatic multiple myeloma eligible for transplant to evaluate the benefit of upfront stem cell transplant
The purpose of the CARDAMON study is: • To determine the efficacy of the triple regimen Carfilzomib, Cyclophosphamide and Dexamethasone (CarCyDex) as induction in untreated patients with symptomatic...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
University College London,
Update Il y a 4 ans
Belimumab after B Cell depletion therapy as a new treatment for patients with systemic lupus erythematosus (SLE)
Background and study aims Systemic lupus erythematosus (SLE) is a long-term (chronic) disease which causes widespread inflammation (swelling) in the body. SLE occurs when the immune system attacks the...
Country
None
organs
None
Specialty
None
Opened trial
More information
Previous
2
3
4
5
6
7
8
9
10
11
Next